anti obr antibody (R&D Systems)
Structured Review
Anti Obr Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+obr/Human+Leptin+R+Antibody/us11965028-257-19-22
Average 93 stars, based on 5 article reviews
Images
Related Articles
Blocking Assay:Article Title: Neuropilin-1-peptide based antibody, highlighting new epitope associated to glycosaminoglycan-modified neuropilin-1 and methods of use thereof Article Snippet: To analyze the a-NRP1_LEP antibody effect on the NRP-1/OBR complex formation, the MDA-MB-231 cells were cultured for two days in human serum (H4522, Sigma) and then treated for two additional days with the mouse a-NRP1_LEP antibody of the invention or its mIgG2b isotype control at 10, 20 or 40 μg/ml, or with the antibody of the prior art a-NRP1_VE and its hIgG1 isotype control at 20 μg/ml. .. After washes, fixation, permeabilization and blocking, cells were incubated with commercial anti-NRP-1 (NBP2-67539, Novus) and Incubation:Article Title: Neuropilin-1-peptide based antibody, highlighting new epitope associated to glycosaminoglycan-modified neuropilin-1 and methods of use thereof Article Snippet: To analyze the a-NRP1_LEP antibody effect on the NRP-1/OBR complex formation, the MDA-MB-231 cells were cultured for two days in human serum (H4522, Sigma) and then treated for two additional days with the mouse a-NRP1_LEP antibody of the invention or its mIgG2b isotype control at 10, 20 or 40 μg/ml, or with the antibody of the prior art a-NRP1_VE and its hIgG1 isotype control at 20 μg/ml. .. After washes, fixation, permeabilization and blocking, cells were incubated with commercial anti-NRP-1 (NBP2-67539, Novus) and Negative Control:Article Title: Neuropilin-1-peptide based antibody, highlighting new epitope associated to glycosaminoglycan-modified neuropilin-1 and methods of use thereof Article Snippet: To analyze the a-NRP1_LEP antibody effect on the NRP-1/OBR complex formation, the MDA-MB-231 cells were cultured for two days in human serum (H4522, Sigma) and then treated for two additional days with the mouse a-NRP1_LEP antibody of the invention or its mIgG2b isotype control at 10, 20 or 40 μg/ml, or with the antibody of the prior art a-NRP1_VE and its hIgG1 isotype control at 20 μg/ml. .. After washes, fixation, permeabilization and blocking, cells were incubated with commercial anti-NRP-1 (NBP2-67539, Novus) and Proximity Ligation Assay:Article Title: Neuropilin-1-peptide based antibody, highlighting new epitope associated to glycosaminoglycan-modified neuropilin-1 and methods of use thereof Article Snippet: To analyze the a-NRP1_LEP antibody effect on the NRP-1/OBR complex formation, the MDA-MB-231 cells were cultured for two days in human serum (H4522, Sigma) and then treated for two additional days with the mouse a-NRP1_LEP antibody of the invention or its mIgG2b isotype control at 10, 20 or 40 μg/ml, or with the antibody of the prior art a-NRP1_VE and its hIgG1 isotype control at 20 μg/ml. .. After washes, fixation, permeabilization and blocking, cells were incubated with commercial anti-NRP-1 (NBP2-67539, Novus) and |

